ArticleScientific reports2019

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.

Tigran Makunts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.